Recruiting PHASE1 INTERVENTIONAL 2-arm NCT03918408

Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking

Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Collagen Cross-Linking in Eyes With Corneal Thinning Conditions

Sponsor: Pacific Clear Vision Institute

Conditions Bacterial Keratitis Ectasia of Cornea Keratoconus, Unstable

Interventions PXL-330 Platinum device for crosslinking with Peschke ribofflavin solution

Updated 9 times since 2019 Last updated: Nov 9, 2024 Started: Sep 1, 2019 Primary completion: Dec 31, 2029 Completion: Dec 31, 2030

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Bacterial Keratitis and Ectasia of Cornea and is currently actively recruiting participants. Pacific Clear Vision Institute leads this study, which shows 9 recorded versions since 2019 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

9 versions recorded

Dec 2024 — Present [monthly]

Recruiting PHASE1
Sep 2024 — Dec 2024 [monthly]

Recruiting PHASE1
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE1
Feb 2023 — Jul 2024 [monthly]

Recruiting PHASE1
Oct 2021 — Feb 2023 [monthly]

Recruiting PHASE1

▶ Show 4 earlier versions

Jan 2021 — Oct 2021 [monthly]

Recruiting PHASE1
Sep 2019 — Jan 2021 [monthly]

Recruiting PHASE1
Jul 2019 — Sep 2019 [monthly]

Recruiting PHASE1

Status: Not Yet Recruiting → Recruiting
May 2019 — Jul 2019 [monthly]

Not Yet Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pacific Clear Vision Institute

Data source: Pacific Clear Vision Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Eugene, United States